117 related articles for article (PubMed ID: 32238134)
21. Identification of Biomarkers Based on Differentially Expressed Genes in Papillary Thyroid Carcinoma.
Han J; Chen M; Wang Y; Gong B; Zhuang T; Liang L; Qiao H
Sci Rep; 2018 Jul; 8(1):9912. PubMed ID: 29967488
[TBL] [Abstract][Full Text] [Related]
22. Microarray profiling of circular RNAs in human papillary thyroid carcinoma.
Peng N; Shi L; Zhang Q; Hu Y; Wang N; Ye H
PLoS One; 2017; 12(3):e0170287. PubMed ID: 28288173
[TBL] [Abstract][Full Text] [Related]
23. Network Analyses of Integrated Differentially Expressed Genes in Papillary Thyroid Carcinoma to Identify Characteristic Genes.
Shang J; Ding Q; Yuan S; Liu JX; Li F; Zhang H
Genes (Basel); 2019 Jan; 10(1):. PubMed ID: 30646607
[TBL] [Abstract][Full Text] [Related]
24. Exosomal miRNAs are potential diagnostic biomarkers between malignant and benign thyroid nodules based on next-generation sequencing.
Pan Q; Zhao J; Li M; Liu X; Xu Y; Li W; Wu S; Su Z
Carcinogenesis; 2020 Mar; 41(1):18-24. PubMed ID: 31560760
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive Identification of Potential Crucial Genes and miRNA-mRNA Regulatory Networks in Papillary Thyroid Cancer.
Nan BY; Xiong GF; Zhao ZR; Gu X; Huang XS
Biomed Res Int; 2021; 2021():6752141. PubMed ID: 33521130
[TBL] [Abstract][Full Text] [Related]
26. Identification of Specific Long Non-Coding RNA Expression: Profile and Analysis of Association with Clinicopathologic Characteristics and BRAF Mutation in Papillary Thyroid Cancer.
Wang Q; Yang H; Wu L; Yao J; Meng X; Jiang H; Xiao C; Wu F
Thyroid; 2016 Dec; 26(12):1719-1732. PubMed ID: 27758138
[TBL] [Abstract][Full Text] [Related]
27. Identification of key genes and miRNAs markers of papillary thyroid cancer.
Qiu J; Zhang W; Zang C; Liu X; Liu F; Ge R; Sun Y; Xia Q
Biol Res; 2018 Nov; 51(1):45. PubMed ID: 30414611
[TBL] [Abstract][Full Text] [Related]
28. Identification of Genes Associated with Papillary Thyroid Carcinoma (PTC) for Diagnosis by Integrated Analysis.
Li WB; Zhou J; Xu L; Su XL; Liu Q; Pang H
Horm Metab Res; 2016 Apr; 48(4):226-31. PubMed ID: 26756467
[TBL] [Abstract][Full Text] [Related]
29. Identification of potential pathogenic candidates or diagnostic biomarkers in papillary thyroid carcinoma using expression and methylation profiles.
Wei S; Yun X; Ruan X; Wei X; Zheng X; Gao M
Oncol Lett; 2019 Dec; 18(6):6670-6678. PubMed ID: 31814850
[TBL] [Abstract][Full Text] [Related]
30. Identification of biomarkers associated with cervical lymph node metastasis in papillary thyroid carcinoma: Evidence from an integrated bioinformatic analysis.
Zhang Z; Zhao S; Wang K; Shang M; Chen Z; Yang H; Chen Y; Chen B
Clin Hemorheol Microcirc; 2021; 78(2):117-126. PubMed ID: 33554894
[TBL] [Abstract][Full Text] [Related]
31. The Profile of Genetic Mutations in Papillary Thyroid Cancer Detected by Whole Exome Sequencing.
Fang Y; Ma X; Zeng J; Jin Y; Hu Y; Wang J; Liu R; Cao C
Cell Physiol Biochem; 2018; 50(1):169-178. PubMed ID: 30278442
[TBL] [Abstract][Full Text] [Related]
32. Gene expression profiling identifies potential molecular markers of papillary thyroid carcinoma.
Reyes I; Reyes N; Suriano R; Iacob C; Suslina N; Policastro A; Moscatello A; Schantz S; Tiwari RK; Geliebter J
Cancer Biomark; 2019; 24(1):71-83. PubMed ID: 30614796
[TBL] [Abstract][Full Text] [Related]
33. New global analysis of the microRNA transcriptome of primary tumors and lymph node metastases of papillary thyroid cancer.
Saiselet M; Gacquer D; Spinette A; Craciun L; Decaussin-Petrucci M; Andry G; Detours V; Maenhaut C
BMC Genomics; 2015 Oct; 16():828. PubMed ID: 26487287
[TBL] [Abstract][Full Text] [Related]
34. Identification of a Recurrent LMO7-BRAF Fusion in Papillary Thyroid Carcinoma.
He H; Li W; Yan P; Bundschuh R; Killian JA; Labanowska J; Brock P; Shen R; Heerema NA; de la Chapelle A
Thyroid; 2018 Jun; 28(6):748-754. PubMed ID: 29768105
[TBL] [Abstract][Full Text] [Related]
35. BRAF-activated WT1 contributes to cancer growth and regulates autophagy and apoptosis in papillary thyroid carcinoma.
Chen X; Lin S; Lin Y; Wu S; Zhuo M; Zhang A; Zheng J; You Z
J Transl Med; 2022 Feb; 20(1):79. PubMed ID: 35123502
[TBL] [Abstract][Full Text] [Related]
36. Genome-wide scanning for CHD1L gene in papillary thyroid carcinoma complicated with type 2 diabetes mellitus.
Kang YY; Li JJ; Sun JX; Wei JX; Ding C; Shi CL; Wu G; Li K; Ma YF; Sun Y; Qiao H
Clin Transl Oncol; 2021 Dec; 23(12):2536-2547. PubMed ID: 34245428
[TBL] [Abstract][Full Text] [Related]
37. Identification of candidate genes associated with papillary thyroid carcinoma pathogenesis and progression by weighted gene co-expression network analysis.
Chen X; Wang R; Xu T; Zhang Y; Li H; Du C; Wang K; Gao Z
Transl Cancer Res; 2021 Feb; 10(2):694-713. PubMed ID: 35116402
[TBL] [Abstract][Full Text] [Related]
38. MiR-30c-5p loss-induced PELI1 accumulation regulates cell proliferation and migration via activating PI3K/AKT pathway in papillary thyroid carcinoma.
Zheng T; Zhou Y; Xu X; Qi X; Liu J; Pu Y; Zhang S; Gao X; Luo X; Li M; Wang X; Dong L; Wang Y; Mao C
J Transl Med; 2022 Jan; 20(1):20. PubMed ID: 34991623
[TBL] [Abstract][Full Text] [Related]
39. Systems Biology Approaches to Investigate Genetic and Epigenetic Molecular Progression Mechanisms for Identifying Gene Expression Signatures in Papillary Thyroid Cancer.
Yeh SJ; Lin CY; Li CW; Chen BS
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31126066
[TBL] [Abstract][Full Text] [Related]
40. Identification of differentially expressed genes in papillary thyroid cancers.
Lee KY; Huang SM; Li S; Kim JM
Yonsei Med J; 2009 Feb; 50(1):60-7. PubMed ID: 19259350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
